Journal of infection and chemotherapy : official journal of the Japan Society of ChemotherapyHumansCOVID-19Immunocompromised HostJapanRetrospective Studies
The continued impact of COVID-19 during the Omicron era on immunocompromised individuals in Japan.
Toshibumi Taniguchi, Mitsuru Hoshino, Ryotaro Ide, Tomoyuki Homma, Keiji Sugiyama, Shinichi Kanazu, Atsushi Maruyama, Kazuhiro Tateda
Published: 202510.1016/j.jiac.2025.102840
Abstract
BACKGROUND: Under Japan's Infectious Disease Act, coronavirus disease-2019 (COVID-19) was reclassified from a category II to a category V infectious disease, changing it from a notifiable disease to a sentinel disease within the surveillance system g…
Preview only. Read the full abstract at the source